You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ETON Sale Disclosure
Opaleye Management Inc. · SEC Form 4 · Filed Jul 7, 2026
Sale
Calculated transaction value
$2.43M
Opaleye Management Inc. 10% owner
ETON
Eton Pharmaceutcials
ETON
Transaction date
Jul 2, 2026
Public filing date
Jul 7, 2026
Filing lag
Filed 5 days later
ETON daily price context
Close on/before transaction
$37.5
Jul 2, 2026
First close after public filing
$36.17
Jul 8, 2026
30-day return after filing
+27.67%
Through Aug 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock, par value $0.001 per share
- Quantity / price
- 65,000 shares @ $37.39
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001493152-26-032394
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$4.77M
Buys / sales
0 / 5
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Eton Pharmaceuticals, Inc. ETON | Sale | Jul 7, 2026 | $767.46K |
| Eton Pharmaceuticals, Inc. ETON | Sale | Jul 7, 2026 | $256.52K |
| Eton Pharmaceuticals, Inc. ETON | Sale | Jul 6, 2026 | $380K |
| Eton Pharmaceuticals, Inc. ETON Current | Sale | Jul 2, 2026 | $2.43M |
| Eton Pharmaceuticals, Inc. ETON | Sale | Jul 2, 2026 | $934.63K |